Coleen Glessner - 01 Mar 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
01 Mar 2024
Net transactions value
-$1,292
Form type
4
Filing time
04 Mar 2024, 18:43:10 UTC
Previous filing
13 Jun 2023
Next filing
15 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $1,292 -381 -0.23% $3.39 164,968 01 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.